Avanos Medical (AVNS) Total Debt (2013 - 2026)

Avanos Medical (AVNS) has 14 years of Total Debt data on file, last reported at $98.2 million in Q1 2026.

• For the quarter ending Q1 2026, Total Debt fell 8.57% year-over-year to $98.2 million; the trailing twelve-month figure through Mar 2026 stood at $98.2 million (down 8.57% YoY), and the FY2025 full-year result was $100.5 million, down 25.39% from the prior year.
• Total Debt retreated to $98.2 million in Q1 2026, from $100.5 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $264.5 million in Q3 2023 to a low of $98.2 million in Q1 2026.
• A 5-year average of $177.1 million and a median of $175.1 million in 2024 frame the typical range for Total Debt.
• Across the five-year window, Total Debt jumped 78.85% in 2022 and tumbled 39.98% in 2025, its largest moves.
• Tracing AVNS's Total Debt over 5 years: stood at $232.5 million in 2022, then dropped by 27.74% to $168.0 million in 2023, then dropped by 19.82% to $134.7 million in 2024, then retreated by 25.39% to $100.5 million in 2025, then fell by 2.29% to $98.2 million in 2026.
• Business Quant data shows AVNS's Total Debt at $98.2 million in Q1 2026, $100.5 million in Q4 2025, and $102.8 million in Q3 2025.